RedHill Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2.87	4.62	5.57	19.97	29.47	29.3
Short-Term Investments	-	-	-	0.02	8.53	0.5
Cash & Short-Term Investments	2.87	4.62	5.57	19.98	38	29.79
Cash Growth	-60.62%	-17.09%	-72.13%	-47.42%	27.56%	-37.77%
Accounts Receivable	5.35	2.54	2.59	34.52	31.68	28.66
Other Receivables	1.01	1.1	2.8	4.39	4.66	5.52
Total Trade Receivables	6.36	3.64	5.39	38.91	36.34	34.18
Inventory	3.17	3.65	4.39	11.01	14.81	6.53
Other Current Assets	0.16	-	0.79	16	-	-
Total Current Assets	12.56	11.91	16.14	85.9	89.15	70.5
Net Property, Plant & Equipment	0.29	0.44	1.18	7.19	4.22	5.7
Other Intangible Assets	5.53	5.55	5.58	65.63	71.64	87.88
Other Long-Term Assets	-	0.15	0.15	0.15	16.17	16.16
Total Assets	18.38	18.04	23.05	158.87	181.19	180.24
Accounts Payable	0.84	1.17	3.28	4.23	11.66	11.55
Accrued Expenses	10.69	9.99	4.59	17.95	20.9	24.08
Short-Term Debt	-	-	-	115.22	-	-
Current Portion of Leases	0.21	0.35	0.72	1.03	1.62	1.71
Other Current Liabilities	10.55	10.71	11.4	59.03	47.29	35.89
Total Current Liabilities	22.29	22.22	19.98	197.45	81.47	73.24
Long-Term Debt	-	-	-	-	83.62	81.39
Long-Term Leases	-	0	0.46	6.44	2.57	3.81
Other Long-Term Liabilities	0.5	0.5	0.54	3.37	4.65	7.95
Total Long-Term Liabilities	0.5	0.5	1	9.82	90.84	93.14
Total Liabilities	22.79	22.73	20.98	207.27	172.31	166.38
Common Stock	63.4	35.04	21.44	2.84	1.5	1.05
Additional Paid-in Capital	350.3	375.08	388.36	382.63	375.25	293.14
Retained Earnings	-418.12	-414.8	-407.74	-433.86	-367.87	-280.33
Shareholders' Equity	-4.41	-4.68	2.07	-48.4	8.88	13.86
Total Liabilities & Equity	18.38	18.04	23.05	158.87	181.19	180.24
Total Debt	0.21	0.36	1.17	122.69	87.81	86.9
Net Cash (Debt)	2.65	4.26	4.4	-102.71	-49.81	-57.11
Net Cash Growth	-37.76%	-3.07%	-	-	-	-
Net Cash Per Share	-	-	-	-	-	-62588.22
Book Value	-4.41	-4.68	2.07	-48.4	8.88	13.86
Book Value Per Share	-	-	-	-	-	15193.89
Tangible Book Value	-9.94	-10.23	-3.51	-114.03	-62.77	-74.02
Tangible Book Value Per Share	-	-	-	-	-	-81114.82

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q